Gene dosage effects of 22q11.2 copy number variants on in-vivo measures of white matter axonal density and dispersion.
Saved in:
| Title: | Gene dosage effects of 22q11.2 copy number variants on in-vivo measures of white matter axonal density and dispersion. |
|---|---|
| Authors: | Boen R; Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA, USA., Villalón-Reina JE; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, CA, USA., Kushan L; Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA, USA., O'Hora KP; Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA, USA., Fung H; Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA, USA., Parker N; Centre for Precision Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital & University of Oslo, Oslo, Norway., Akkouh IA; Centre for Precision Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital & University of Oslo, Oslo, Norway.; Department of Medical Genetics, Oslo University Hospital & University of Oslo, Oslo, Norway., Alnæs D; Centre for Precision Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital & University of Oslo, Oslo, Norway., O'Hara R; Stanford University School of Medicine, Stanford, CA, USA., Marzelli MJ; Stanford University School of Medicine, Stanford, CA, USA., Foland-Ross L; Stanford University School of Medicine, Stanford, CA, USA., Chick CF; Stanford University School of Medicine, Stanford, CA, USA., Cotto I; Stanford University School of Medicine, Stanford, CA, USA., Reiss AL; Stanford University School of Medicine, Stanford, CA, USA., Hallmayer J; Stanford University School of Medicine, Stanford, CA, USA., Thompson PM; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, CA, USA., Andreassen OA; Centre for Precision Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital & University of Oslo, Oslo, Norway.; KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway., Sønderby IE; Centre for Precision Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital & University of Oslo, Oslo, Norway.; Department of Medical Genetics, Oslo University Hospital & University of Oslo, Oslo, Norway.; KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway., Bearden CE; Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA, USA. cbearden@mednet.ucla.edu.; Department of Psychology, University of California Los Angeles, Los Angeles, CA, USA. cbearden@mednet.ucla.edu. |
| Source: | Molecular psychiatry [Mol Psychiatry] 2026 Jul; Vol. 31 (7), pp. 3687-3698. Date of Electronic Publication: 2026 Feb 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5578 (Electronic) Linking ISSN: 13594184 NLM ISO Abbreviation: Mol Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
